PHI 40/16

Page last updated: 02 June 2016

PHI 40/16 – Private Health Insurance (Benefit Requirements) Amendment Rules 2016 (No.3) (PDF 87 KB)


Changes to the Private Health Insurance (Benefit Requirements) Rules 2011

The Private Health Insurance (Benefit Requirements) Amended Rules 2016 (No.3) (the Amendment Rules) were registered with the Federal Register of Legislative Instruments (FRLI) and commenced on 2 June 2016 (FRL No. F2016L00979).

These Amendment Rules amend the Private Health Insurance (Benefit Requirements) Rules 2011.

Medical Benefits Schedule (MBS) item numbers 32088 and 32089

These Amendment Rules reclassify two MBS items (32088 and 32089) from Type A to Type B procedures to correct an error in the previous classification.

Schedule – Amendments

Item 1 - Schedule 1, Part 2 – Type A Procedures, Clause 6 Surgical patient, Subclause (3)
Item 1 amends Schedule 1, Part 2 – Type A Procedures, Clause 6 Surgical patient, Subclause (3) of the Principal Rules by removing MBS items 32088 and 32089. These items were incorrectly classified as Type A, and therefore have been removed from Type A and reclassified as Type B procedures.

Item 2 – Schedule 3, Part 2 – Type B Procedures, Clause 4 Band 1, Subclause (1)(a) T8: Surgical Operations
Item 2 amends Schedule 3, Part 2 – Type B Procedures, Clause 4 Band 1, Subclause (1)(a) T8: Surgical Operations of the Principal rules by inserting item 32088. This is an item for Fibreoptic Colonoscopy examination of the colon beyond the hepatic flexure with or without biopsy, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program.

Item 3 – Schedule 3, Part 2 – Type B Procedures, Clause 5 Non-band specific Type B day procedures, Clause 1
Item 3 amends Schedule 3, Part 2 – Type B Procedures, Clause 5 Non-band specific Type B day procedures, Clause 1 of the Principal Rules by inserting item 32089. This is an item for Endoscopic examination of the colon beyond the hepatic flexure by Fiberoptic Colonoscopy for the removal of 1 or more polyps, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program.

Details of the amendments are set out in the Amendment Rules, which are available on the Federal Register of Legislation website.